Department of Pharmacology and Pharmacy, The University of Hong Kong

Dr. Carlos K.H. WONG 黃競浩

Dr. Connie W.H. WOO

Assistant Professor

  • BSc, MPhil, PhD
Biography

Dr Carlos Wong is currently an Assistant Professor at the Department of Pharmacology and Pharmacy and Department of Family Medicine and Primary Care of The University of Hong Kong. He obtained his PhD in quality of life ('Health-related Quality of Life of Chinese Patients with Colorectal Neoplasms') at the University of Hong Kong. Prior to his PhD, He received his Bachelor and MPhil degrees from Department of Mathematics at Hong Kong University of Science and Technology.

His current research interests are pharmacoepidemiology, and health services research, particularly retrospective administrative database research and cost-effectiveness analysis of health care interventions. He has published more than 170 articles in peer-reviewed journals in field of quality of life, health economics, evaluation of primary and secondary care interventions. He was appointed as member of editorial board of journal 'The Patient - Patient-Centered Outcomes Research', and statistical advisor of 'Hong Kong Medical Journal'. Dr Carlos Wong was awarded the Glasgow / HKU early career mobility fund to be visiting researcher at Health Economics and Health Technology Assessment (HEHTA), University of Glasgow in 2016, and was received the HMRF Research Fellowship in 2017 to be academic visitor at Health Economics Research Centre, University of Oxford in 2019.

Office: 2/F, 21 Sassoon Road, Li Ka Shing Faculty of Medicine, Laboratory Block, Faculty of Medicine Building, Hong Kong SAR, China.

Office: 2/F, 21 Sassoon Road, Li Ka Shing Faculty of Medicine, Laboratory Block, Faculty of Medicine Building, Hong Kong SAR, China.


Memberships

Memberships:

  • Council Member, World Association for Chinese Quality of Life

Editorships:

  • Editorial Board Member – The Patients – Patient-Centered Outcomes Research
  • Statistical Editor – Hong Kong Medical Journal
Honours and Awards
  • Best Poster Award Finalist (Top 10% research poster presentations): International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Glasgow, UK; 2017
  • Excellent Research Award, Health Research Symposium 2017: Health and Medical Research Fund, Food & Health Bureau, the Government of HKSAR; 2017
  • Winner of Best Student Poster Presentation Award, 19th Annual Conference of the International Society for Quality of Life Research, Budapest Marriott, Budapest, Hungary, 2012
  • Wong Ching Yee Medical Postgraduate Scholarships: The University of Hong Kong; 2011-2012
  • Young QOL Researchers Scholarship: Hong Kong Society of Quality of Life; 2010
  • Winner of Best Student Oral Presentation Award on 17th Annual Conference of the International Society for Quality of Life Research, London, United Kingdom; 2010

Research Interests
  • Pharmacoepidemiology and health economics study
  • Economic Evaluation and Cost-effectiveness Analysis of primary and secondary care interventions in Chinese population
  • Psychometric Validation on generic and disease-specific Health-related Quality of Life instruments

Publications
Publications Highlights
  • Wong, C. K., et al. (2019). "Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study." PLoS medicine 16(12): e1002999.
Selected Publications
  • Wu, T. …, Wong, C.K*. “Bariatric surgery is expensive but improves comorbidity: Five-year assessment of patients with obesity and type 2 diabetes.” British Journal of Surgery 2020 DOI: 10.1002/bjs.11970 * Corresponding author
  • Wong, C. K., et al. (2020). "Impact of National Containment Measures on Decelerating the Increase in Daily New Cases of COVID-19 in 54 Countries and 4 Epicenters of the Pandemic: Comparative Observational Study." Journal of Medical Internet Research 22(7): e19904.
  • Wong, C. K., et al. (2015). "Patient Empowerment Programme in primary care reduced all‐cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population‐based propensity‐matched cohort study." Diabetes, Obesity and Metabolism 17(2): 128-135.
  • Wong, C. K., et al. (2018). "Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality." Diabetes, Obesity and Metabolism 20(6): 1470-1478.
  • Wong, C. K., et al. (2019). "Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population‐based cohort study." Diabetes, Obesity and Metabolism 21(6): 1330-1339.
  • Wong, C. K., et al. (2015). "Patient Empowerment Programme (PEP) and risk of microvascular diseases among patients with type 2 diabetes in primary care: a population-based propensity-matched cohort study." Diabetes Care 38(8): e116-e117

Funding
Funding

Principal Investigator in External Competitive Grants

  • 2020-2023 Long-term impact of thyroidectomy on effectiveness and cost-effectiveness for relapsed Graves’ disease. Health and Medical Research, Food and Health Bureau. (HK$ 1,186,959)
  • 2020-2021 Effectiveness of single and combined anti-COVID-19 drugs among hospitalized COVID-19 patients in Hong Kong. Commissioned Research on COVID-19, Food and Health Bureau. (HK$ 482,960)
  • 2019-2020 Psychometric testing of proxy EQ-5D-5L-Y in caregivers of paediatric patients with idiopathic scoliosis. Euroqol Research Foundation. (HK$ 64,500)
  • 2019-2020 Agreement between proxy EQ 5D Y and self reported EQ 5D Y in a paediatric patient group. Euroqol Research Foundation. (HK$ 45,000)
  • 2019-2021 Elicitation of health state utilities for paediatric populations from the general public. General Research Fund. (HK$ 968,347)
  • 2017-2019 A cost-effectiveness threshold of body mass index for undergoing bariatric surgery for obese patients. Health and Medical Research Fund Research Fellowship Scheme, Food and Health Bureau. (HK$ 1,166,684)
  • 2016-2017 Cost and Cost-effectiveness Analysis of Renal Replacement Therapy Modalities for Patients with End-stage Renal Disease in Hong Kong: Comparison between Peritoneal Dialysis and Haemodialysis Strategies. Health and Medical Research Fund, Food and Health Bureau. (HK$526,952) Completed with final report graded as ‘5-excellent’

Other Information
Office

2/F, 21 Sassoon Road, Li Ka Shing Faculty of Medicine, Laboratory Block, Faculty of Medicine Building, Hong Kong SAR, China